Democratic Republic of the Congo

Key Drug Used in Recent Mpox Outbreak Found Ineffective Against Deadly Clade-1 Strain

Recent research reveals that the antiviral drug tecovirimat, used during the global mpox outbreak in 2022-23, did not significantly reduce the duration of sores for those infected with the Clade 1 strain of the mpox virus. This strain has been prevalent in the Democratic Republic of the Congo (DRC) since...